Skip to main content
. Author manuscript; available in PMC: 2013 Aug 20.
Published in final edited form as: Cancer. 2011 Oct 5;118(10):2632–2640. doi: 10.1002/cncr.26586

Table 2.

Treatment Characteristics and Outcomes

Characteristic All
Patients
(n=239)
Patients with
T1/T2 Tumors
(n=31)
Patients with
T3/T4 Tumors
(n=208)
Induction chemotherapy
 Yes 111 (46%)
 No 128 (54%)
Concurrent chemotherapy
 Yes 237 (99%)
 No 2 (1%)
Radiation dose, Gy
 median (range) 50.4 (32.4-66)
Initial Max. SUV
 median (range) 11.7 (0-51)
Post treatment Max. SUV
 median (range) 4.4 (0-19.9)
Outcomes
 Local failure 119 (50%) 7 (23%) 112 (54%)
   GTV failure 107 (90%) 6 (86%) 101 (90%)
   CTV failure 27 (23%) 3 (43%) 24 (21%)
   PTV failure 14 (12%) 0 (0%) 14 (12%)
  Distant failure 114 (48%) 6 (19%) 108 (52%)
  No evidence of disease 74 (31%) 22 (71%) 52 (25%)

Abbreviations: SUV, standardized uptake value; GTV, gross tumor volume; CTV, clinical target volume; PTV, planning target volume.

HHS Vulnerability Disclosure